Primary adenocarcinoma of the uterine cervix. A clinical study
In a retrospective clinical study, 67 matched cases of primary adenocarcinoma and squamous cell carcinoma of the cervix were compared. The mean age, weight, and menopausal age of women with adenocarcinoma of the cervix were in excess of the corresponding figures for squamous cell carcinoma. There wa...
Gespeichert in:
| Veröffentlicht in: | Cancer 1983-09, Vol.52 (5), p.942-947 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 947 |
|---|---|
| container_issue | 5 |
| container_start_page | 942 |
| container_title | Cancer |
| container_volume | 52 |
| creator | Milsom, Ian Friberg, Lars Gösta |
| description | In a retrospective clinical study, 67 matched cases of primary adenocarcinoma and squamous cell carcinoma of the cervix were compared. The mean age, weight, and menopausal age of women with adenocarcinoma of the cervix were in excess of the corresponding figures for squamous cell carcinoma. There was a significantly (P < 0.05) larger number of diabetics and nulliparous women amongst the patients with adenocarcinoma of the cervix. Blood group A was significantly (P < 0.05) more frequent in patients with cervix cancer. Treatment choice was independent of the tumors histological type. The five‐year survival rates for adenocarcinoma of the cervix were 83.3% (Stage IB), 60.0% (Stage IIA), and 45.5% (Stage IIB). The corresponding five‐year survival rates for squamous cell carcinoma were 90.0%, 73.3%, and 40.9%. There were indications that adenocarcinoma of the cervix was less radiosensitive than squamous cell carcinoma. Estrogen substitution following treatment of adenocarcinoma of the cervix did not adversely affect the outcome. |
| doi_str_mv | 10.1002/1097-0142(19830901)52:5<942::AID-CNCR2820520534>3.0.CO;2-R |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80566253</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80566253</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4954-e7e65a2ebae2e2009cdbb18913ee1d736ea6454704e98dd736eb41aad04186993</originalsourceid><addsrcrecordid>eNqVkN2LEzEUxYMoa7f6JwjzIOI-TL35mkmqLNTxa2GxUhTEl0smc4sj05k16aj9701tLeiDIARC7jk5nPtj7DmHGQcQTzjYMgeuxGNujQQL_EKLuX5mlZjPF1cv8upttRJGgE5Hqks5g1m1fCry1S02OX2-zSYAYHKt5Me77DzGL-lZCi3P2FlhSm6kmrDLd6HduLDLXEP94F3wbT9sXDass-1nysYthbanzFP41v6YZYvMd23fetdlcTs2u3vsztp1ke4f7yn78Orl--pNfr18fVUtrnOvrFY5lVRoJ6h2JEgAWN_UNTeWSyLelLIgVyitSlBkTfNrUCvuXAOKm8JaOWWPDrk3Yfg6Utzipo2eus71NIwRDeiiSKsl46eD0YchxkBrvDksiBxwDxf3fHDPB3_DRS1QY4KLmODin3BRImC1RIGrFP7g2GKsN9Scoo80k_7wqLuYEK2D630bTzYrCylTySmjg-1729Huvwr-s99fivwJNh2inA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80566253</pqid></control><display><type>article</type><title>Primary adenocarcinoma of the uterine cervix. A clinical study</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Milsom, Ian ; Friberg, Lars Gösta</creator><creatorcontrib>Milsom, Ian ; Friberg, Lars Gösta</creatorcontrib><description>In a retrospective clinical study, 67 matched cases of primary adenocarcinoma and squamous cell carcinoma of the cervix were compared. The mean age, weight, and menopausal age of women with adenocarcinoma of the cervix were in excess of the corresponding figures for squamous cell carcinoma. There was a significantly (P < 0.05) larger number of diabetics and nulliparous women amongst the patients with adenocarcinoma of the cervix. Blood group A was significantly (P < 0.05) more frequent in patients with cervix cancer. Treatment choice was independent of the tumors histological type. The five‐year survival rates for adenocarcinoma of the cervix were 83.3% (Stage IB), 60.0% (Stage IIA), and 45.5% (Stage IIB). The corresponding five‐year survival rates for squamous cell carcinoma were 90.0%, 73.3%, and 40.9%. There were indications that adenocarcinoma of the cervix was less radiosensitive than squamous cell carcinoma. Estrogen substitution following treatment of adenocarcinoma of the cervix did not adversely affect the outcome.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19830901)52:5<942::AID-CNCR2820520534>3.0.CO;2-R</identifier><identifier>PMID: 6871834</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adenocarcinoma - pathology ; Adenocarcinoma - radiotherapy ; Adenocarcinoma - surgery ; Adult ; Age Factors ; Biological and medical sciences ; Blood Grouping and Crossmatching ; Body Weight ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - radiotherapy ; Carcinoma, Squamous Cell - surgery ; Female ; Female genital diseases ; Gynecology. Andrology. Obstetrics ; Humans ; Hysterectomy ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Sweden ; Tumors ; Uterine Cervical Neoplasms - pathology ; Uterine Cervical Neoplasms - radiotherapy ; Uterine Cervical Neoplasms - surgery</subject><ispartof>Cancer, 1983-09, Vol.52 (5), p.942-947</ispartof><rights>Copyright © 1983 American Cancer Society</rights><rights>1984 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4954-e7e65a2ebae2e2009cdbb18913ee1d736ea6454704e98dd736eb41aad04186993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9363325$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6871834$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Milsom, Ian</creatorcontrib><creatorcontrib>Friberg, Lars Gösta</creatorcontrib><title>Primary adenocarcinoma of the uterine cervix. A clinical study</title><title>Cancer</title><addtitle>Cancer</addtitle><description>In a retrospective clinical study, 67 matched cases of primary adenocarcinoma and squamous cell carcinoma of the cervix were compared. The mean age, weight, and menopausal age of women with adenocarcinoma of the cervix were in excess of the corresponding figures for squamous cell carcinoma. There was a significantly (P < 0.05) larger number of diabetics and nulliparous women amongst the patients with adenocarcinoma of the cervix. Blood group A was significantly (P < 0.05) more frequent in patients with cervix cancer. Treatment choice was independent of the tumors histological type. The five‐year survival rates for adenocarcinoma of the cervix were 83.3% (Stage IB), 60.0% (Stage IIA), and 45.5% (Stage IIB). The corresponding five‐year survival rates for squamous cell carcinoma were 90.0%, 73.3%, and 40.9%. There were indications that adenocarcinoma of the cervix was less radiosensitive than squamous cell carcinoma. Estrogen substitution following treatment of adenocarcinoma of the cervix did not adversely affect the outcome.</description><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma - radiotherapy</subject><subject>Adenocarcinoma - surgery</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Biological and medical sciences</subject><subject>Blood Grouping and Crossmatching</subject><subject>Body Weight</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - radiotherapy</subject><subject>Carcinoma, Squamous Cell - surgery</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Hysterectomy</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Sweden</subject><subject>Tumors</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Uterine Cervical Neoplasms - radiotherapy</subject><subject>Uterine Cervical Neoplasms - surgery</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkN2LEzEUxYMoa7f6JwjzIOI-TL35mkmqLNTxa2GxUhTEl0smc4sj05k16aj9701tLeiDIARC7jk5nPtj7DmHGQcQTzjYMgeuxGNujQQL_EKLuX5mlZjPF1cv8upttRJGgE5Hqks5g1m1fCry1S02OX2-zSYAYHKt5Me77DzGL-lZCi3P2FlhSm6kmrDLd6HduLDLXEP94F3wbT9sXDass-1nysYthbanzFP41v6YZYvMd23fetdlcTs2u3vsztp1ke4f7yn78Orl--pNfr18fVUtrnOvrFY5lVRoJ6h2JEgAWN_UNTeWSyLelLIgVyitSlBkTfNrUCvuXAOKm8JaOWWPDrk3Yfg6Utzipo2eus71NIwRDeiiSKsl46eD0YchxkBrvDksiBxwDxf3fHDPB3_DRS1QY4KLmODin3BRImC1RIGrFP7g2GKsN9Scoo80k_7wqLuYEK2D630bTzYrCylTySmjg-1729Huvwr-s99fivwJNh2inA</recordid><startdate>19830901</startdate><enddate>19830901</enddate><creator>Milsom, Ian</creator><creator>Friberg, Lars Gösta</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19830901</creationdate><title>Primary adenocarcinoma of the uterine cervix. A clinical study</title><author>Milsom, Ian ; Friberg, Lars Gösta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4954-e7e65a2ebae2e2009cdbb18913ee1d736ea6454704e98dd736eb41aad04186993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma - radiotherapy</topic><topic>Adenocarcinoma - surgery</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Biological and medical sciences</topic><topic>Blood Grouping and Crossmatching</topic><topic>Body Weight</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - radiotherapy</topic><topic>Carcinoma, Squamous Cell - surgery</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Hysterectomy</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Sweden</topic><topic>Tumors</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Uterine Cervical Neoplasms - radiotherapy</topic><topic>Uterine Cervical Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Milsom, Ian</creatorcontrib><creatorcontrib>Friberg, Lars Gösta</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Milsom, Ian</au><au>Friberg, Lars Gösta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary adenocarcinoma of the uterine cervix. A clinical study</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1983-09-01</date><risdate>1983</risdate><volume>52</volume><issue>5</issue><spage>942</spage><epage>947</epage><pages>942-947</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>In a retrospective clinical study, 67 matched cases of primary adenocarcinoma and squamous cell carcinoma of the cervix were compared. The mean age, weight, and menopausal age of women with adenocarcinoma of the cervix were in excess of the corresponding figures for squamous cell carcinoma. There was a significantly (P < 0.05) larger number of diabetics and nulliparous women amongst the patients with adenocarcinoma of the cervix. Blood group A was significantly (P < 0.05) more frequent in patients with cervix cancer. Treatment choice was independent of the tumors histological type. The five‐year survival rates for adenocarcinoma of the cervix were 83.3% (Stage IB), 60.0% (Stage IIA), and 45.5% (Stage IIB). The corresponding five‐year survival rates for squamous cell carcinoma were 90.0%, 73.3%, and 40.9%. There were indications that adenocarcinoma of the cervix was less radiosensitive than squamous cell carcinoma. Estrogen substitution following treatment of adenocarcinoma of the cervix did not adversely affect the outcome.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>6871834</pmid><doi>10.1002/1097-0142(19830901)52:5<942::AID-CNCR2820520534>3.0.CO;2-R</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 1983-09, Vol.52 (5), p.942-947 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80566253 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adenocarcinoma - pathology Adenocarcinoma - radiotherapy Adenocarcinoma - surgery Adult Age Factors Biological and medical sciences Blood Grouping and Crossmatching Body Weight Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - radiotherapy Carcinoma, Squamous Cell - surgery Female Female genital diseases Gynecology. Andrology. Obstetrics Humans Hysterectomy Medical sciences Middle Aged Neoplasm Staging Prognosis Retrospective Studies Sweden Tumors Uterine Cervical Neoplasms - pathology Uterine Cervical Neoplasms - radiotherapy Uterine Cervical Neoplasms - surgery |
| title | Primary adenocarcinoma of the uterine cervix. A clinical study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A49%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20adenocarcinoma%20of%20the%20uterine%20cervix.%20A%20clinical%20study&rft.jtitle=Cancer&rft.au=Milsom,%20Ian&rft.date=1983-09-01&rft.volume=52&rft.issue=5&rft.spage=942&rft.epage=947&rft.pages=942-947&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/1097-0142(19830901)52:5%3C942::AID-CNCR2820520534%3E3.0.CO;2-R&rft_dat=%3Cproquest_cross%3E80566253%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80566253&rft_id=info:pmid/6871834&rfr_iscdi=true |